Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after doxorubicin treatment in rats
dc.contributor.author | Santos, Ronaldo Vagner Thomatieli dos [UNIFESP] | |
dc.contributor.author | Batista, Miguel L. | |
dc.contributor.author | Caperuto, Erico C. | |
dc.contributor.author | Costa Rosa, Luis F. B. P. | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Univ Mogi das Cruzes | |
dc.date.accessioned | 2016-01-24T13:49:16Z | |
dc.date.available | 2016-01-24T13:49:16Z | |
dc.date.issued | 2007-12-01 | |
dc.description.abstract | 1. Doxorubicin is an anti-cancer drug with well-described effects against a wide range of tumours. However, doxorubicin also exhibits dose-dependent cytotoxicity. the purpose of the present study was to determine whether chronic supplementation of creatine or a mix of vitamins C and E could increase survival and improve plasma parameters 48 h after doxorubicin treatment.2. Rats were divided into four groups: (i) saline (control); (ii) doxorubicin treated; (iii) a creatine (0.2 g/kg per day)-supplemented group; and (iv) a vitamin C (250 mg/kg per day) and E (400 IU/kg per day)-supplemented group. After 30 days supplementation of rats with either creatine or the vitamins, one dose of doxorubicin (15 mg/kg, i.p.) was administered.3. There was no difference in weight loss among the groups until the 3rd day after doxorubicin treatment, but the creatine- and vitamin-supplemented groups lived longer compared with the doxorubicin only treated group (6, 7 and 3 days, respectively). the doxorubicin-treated group lost 13.4% bodyweight over 3 days, whereas the creatine- and vitamin-supplemented groups lost approximately 35% 3 days after the administration of doxorubicin. Doxorubicin treatment resulted in an increase in alanine aminotransferase (ALT; P < 0.05), lactate dehydrogenase (LDH; P < 0.05), urea (P < 0.05) and creatinine (P < 0.05) compared with levels observed in the control group. Conversely, creatine supplementation promoted a partial return to control values for LDH (P < 0.05) and creatinine (P < 0.05), whereas the vitamin mix reversed the changes in ALT (P < 0.05), LDH (P < 0.05), urea (P < 0.05) and creatinine (P < 0.05).4. in conclusion, the results of the present study indicate that the two supplementation protocols decreased the cytotoxic effects of doxorubicin and that a protective effect was more noticeable in animals supplemented with the mixture of vitamins C and E. | en |
dc.description.affiliation | Univ São Paulo, Inst Biomed Sci, Lab Metab, Baixada Santista, Brazil | |
dc.description.affiliation | Universidade Federal de São Paulo, Dept Hlth Sci, Baixada Santista, Brazil | |
dc.description.affiliation | Univ Mogi das Cruzes, Sch Phys Educ, São Paulo, Brazil | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Dept Hlth Sci, Baixada Santista, Brazil | |
dc.description.source | Web of Science | |
dc.format.extent | 1294-1299 | |
dc.identifier | https://onlinelibrary.wiley.com/doi/full/10.1111/j.1440-1681.2007.04717.x | |
dc.identifier.citation | Clinical and Experimental Pharmacology and Physiology. Oxford: Blackwell Publishing, v. 34, n. 12, p. 1294-1299, 2007. | |
dc.identifier.doi | 10.1111/j.1440-1681.2007.04717.x | |
dc.identifier.issn | 0305-1870 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/30199 | |
dc.identifier.wos | WOS:000250435100014 | |
dc.language.iso | eng | |
dc.publisher | Blackwell Publishing | |
dc.relation.ispartof | Clinical and Experimental Pharmacology and Physiology | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | Adriamycin | en |
dc.subject | Cellular damage | en |
dc.subject | Creatine | en |
dc.subject | Injury | en |
dc.subject | Vitamin C | en |
dc.subject | Vitamin E | en |
dc.title | Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after doxorubicin treatment in rats | en |
dc.type | info:eu-repo/semantics/article |